159 related articles for article (PubMed ID: 17168727)
1. Arginine mimetic structures in biologically active antagonists and inhibitors.
Masic LP
Curr Med Chem; 2006; 13(30):3627-48. PubMed ID: 17168727
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases.
Huang H; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2000 Jul; 43(15):2938-45. PubMed ID: 10956202
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes.
Ijuin R; Umezawa N; Nagai S; Higuchi T
Bioorg Med Chem Lett; 2005 Jun; 15(11):2881-5. PubMed ID: 15911272
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
[TBL] [Abstract][Full Text] [Related]
6. Conformationally-restricted arginine analogues as alternative substrates and inhibitors of nitric oxide synthases.
Lee Y; Marletta MA; Martasek P; Roman LJ; Masters BS; Silverman RB
Bioorg Med Chem; 1999 Jun; 7(6):1097-104. PubMed ID: 10428379
[TBL] [Abstract][Full Text] [Related]
7. Aspartate and glutamate mimetic structures in biologically active compounds.
Stefanic P; Dolenc MS
Curr Med Chem; 2004 Apr; 11(8):945-68. PubMed ID: 15078158
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of the thrombin selectivity of a ligand that contains the constrained arginine mimic (2S)-2-amino-(3S)-3-(1-carbamimidoyl- piperidin-3-yl)-propanoic acid at P1.
Narasimhan LS; Rubin JR; Holland DR; Plummer JS; Rapundalo ST; Edmunds JE; St-Denis Y; Siddiqui MA; Humblet C
J Med Chem; 2000 Feb; 43(3):361-8. PubMed ID: 10669563
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological testing of potential heme-coordinating nitric oxide synthase inhibitors.
Litzinger EA; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem; 2006 May; 14(9):3185-98. PubMed ID: 16431112
[TBL] [Abstract][Full Text] [Related]
12. Design of isoform-selective inhibitors of nitric oxide synthase.
Babu BR; Griffith OW
Curr Opin Chem Biol; 1998 Aug; 2(4):491-500. PubMed ID: 9736922
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic manipulation of nitric oxide signaling: targeting NOS dimerization and protein-protein interactions.
Paige JS; Jaffrey SR
Curr Top Med Chem; 2007; 7(1):97-114. PubMed ID: 17266598
[TBL] [Abstract][Full Text] [Related]
15. Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Roman LJ; Martásek P; Silverman RB
J Med Chem; 2001 Aug; 44(16):2667-70. PubMed ID: 11472219
[TBL] [Abstract][Full Text] [Related]
16. Diastereoselective functionalizations of enecarbamates derived from pipecolic acid towards 5-guanidinopipecolates as arginine mimetics.
Le Corre L; Kizirian JC; Levraud C; Boucher JL; Bonnet V; Dhimane H
Org Biomol Chem; 2008 Sep; 6(18):3388-98. PubMed ID: 18802647
[TBL] [Abstract][Full Text] [Related]
17. Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.
Cinelli MA; Li H; Chreifi G; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2014 Feb; 57(4):1513-30. PubMed ID: 24472039
[TBL] [Abstract][Full Text] [Related]
18. Dipeptides containing L-arginine analogs: new isozyme-selective inhibitors of nitric oxide synthase.
Kobayashi N; Higuchi T; Urano Y; Kikuchi K; Hirobe M; Nagano T
Biol Pharm Bull; 1999 Sep; 22(9):936-40. PubMed ID: 10513616
[TBL] [Abstract][Full Text] [Related]
19. Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics.
Peterlin-Masic L; Mlinsek G; Solmajer T; Trampus-Bakija A; Stegnar M; Kikelj D
Bioorg Med Chem Lett; 2003 Mar; 13(5):789-94. PubMed ID: 12617892
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase inhibitors enhance 5-HT2 receptor-mediated behavior, the head-twitch response in mice.
Kim HS; Son YR; Kim SH
Life Sci; 1999; 64(26):2463-70. PubMed ID: 10403505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
